Contact

Click here for a confidential contact or call:

1-212-350-2774

FCA Federal

This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:

Page 110 of 182

January 31, 2018

Florida Technical College, Inc. agreed to pay $600,000 to settle claims it violated the False Claims Act through the college’s Cutler Bay Campus falsely certifying compliance with federal student aid programs’ eligibility requirements and submitting claims for 27 ineligible students. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Laurie Astacio, a former administrative assistant in the Cutler Bay admissions office. She will receive a whistleblower award from the proceeds of the government’s recovery. DOJ (SDFL)

January 31, 2018

Brooklyn-based home health care company Home Family Care, Inc. and its co-owner and president agreed to pay roughly $6.4 million to settle claims they violated the False Claims Act by billing Medicaid for home health care services the company did not provide to Medicaid recipients. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act. DOJ (EDPA)

January 30, 2018

Tampa’s largest ambulance providers AmeriCare Ambulance Service, Inc. and its sister company AmeriCare ALS, Inc. agreed to pay roughly $5.5 million to settle claims they violated the False Claims Act by billing Medicare for medically unnecessary ambulance transportation services. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by former AmeriCare employee Ernest Sharp. He will receive a whistleblower award of roughly $1.15 million from the proceeds of the government’s recovery. DOJ (MDFL)

January 25, 2018

Primex Clinical Laboratories, LLC agreed to pay $3.5 million to settle claims it violated the False Claims Act and Anti-Kickbacks Statue by paying kickbacks in exchange for laboratory referrals for patient pharmacogenetic testing. The allegations originated by a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by former sales reps Don Pyburn and David Choate. They will receive a whistleblower award of $754,000 from the proceeds of the government’s recovery. DOJ (NDTX)

January 24, 2018

Tennessee chiropractor Matthew Anderson agreed to pay $1.45 million to resolve allegations he violated the False Claims Act. Specifically, the government alleged that Anderson and his management company, PMC LLC, caused pharmacies to submit requests for Medicare and TennCare payments for pain killers dispensed based upon prescriptions written at the Cookeville Center for Pain Management, one of the pain clinics Anderson managed, which had no legitimate medical purpose. The government further alleged that Anderson caused four pain clinics he managed to bill Medicare for upcoded claims for office visits that were not reimbursable at the levels sought. The allegations originated in a whistleblower lawsuit filed by a former office manager for the Cookeville Center for Pain Management under the qui tam provisions of the False Claims Act. The whistleblower will receive a whistleblower award of $246,500 from the proceeds of the government's recovery. DOJ

January 23, 2018

Drs. Aytac Apaydin and Stephen Worsham, urologists based in Northern California who own Salinas Valley Urology Associates and formerly owned Advance Radiation Oncology Center, will pay roughly $1 million to settle claims they violated the False Claims Act by submitting claims to Medicare for image guided radiation therapy (IGRT) that was referred and billed in violation of the physician self-referral law (the “Stark Law”) and the Anti-Kickback Statute. DOJ

Armstrong Case Shows Whistleblowers Are Key to Doping Fix: Constantine Cannon Lawyers Weigh In

Posted  04/25/18
By the C|C Whistleblower Lawyer Team Last week, cyclist Lance Armstrong agreed to pay the United States $5 million to settle False Claims Act allegations surrounding his doping scandal, in which he admitted to using performance-enhancing drugs while racing under a U.S. Postal Service sponsorship. The settlement resolved a lawsuit filed in 2010 by whistleblower Floyd Landis-who himself participated in the scheme as...

Blowing the Whistle on Tariff Dodgers

Posted  04/23/18
By Anne Hayes Hartman
containers at port with cranes
Faced with higher tariffs, some importers seek unlawful means to avoid those costs.  As tariff evasion schemes multiply and become more valuable, whistleblowers can play a critical role in exposing these schemes, and can receive a financial reward for doing so. In an article titled Tariff Dodgers Stand to Profit Off U.S.-China Trade Dispute, the New York Times described the schemes that companies importing goods...

Supreme Court Considers Revisiting Key FCA Decision

Posted  04/17/18
Supreme CourtBy the C|C Whistleblower Lawyer Team Yesterday, the justices asked the Trump Administration’s Office of the Solicitor General’s views on a petition for certiorari in United States ex rel. Campie v. Gilead Scis., a False Claims Act (FCA) suit against pharmaceutical giant Gilead Sciences. The suit, which was brought by two former Gilead employees turned whistleblowers, alleges the company made false statements...
1 108 109 110 111 112 182